SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratories informs about newspaper publication

30 Jul 2025 Evaluate

Zenotech Laboratories has informed that it enclosed copies of extracts of Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2025 in Business Standard (English Newspaper) all editions and Telugu Prabha (Telugu Newspaper) Hyderabad edition.

The above information is a part of company’s filings submitted to BSE.

Zenotech Labs. Share Price

45.70 0.68 (1.51%)
10-Jul-2026 12:43 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1931.50
Dr. Reddys Labs. 1246.70
Cipla 1442.00
Zydus Lifesciences 1149.15
Lupin 2504.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: